...
首页> 外文期刊>International Journal of Biochemistry Research & Review >Assessment of Apo-B and TG/HDL-C Ratio asIndicators of Insulin Resistance in Patients withMetabolic Syndrome
【24h】

Assessment of Apo-B and TG/HDL-C Ratio asIndicators of Insulin Resistance in Patients withMetabolic Syndrome

机译:代谢综合征患者中Apo-B和TG / HDL-C比值作为胰岛素抵抗指标的评估

获取原文
           

摘要

Objectives: The aim of the present study was to assess Apolipoprotein B (Apo-B) and Triglyceride/High Density Lipoprotein Cholesterol (TG/HDL-C) ratio as indicators of insulin resistance (IR) with Homeostasis Model of assessment of insulin resistance (HOMA IR)) in metabolic syndrome patients .Study Design: Observational and prospective.Place and Duration of Study: The study was carried out in Department of Biochemistry and Department of Medicine, MGM Medical College, Navi-Mumbai from March 2012 to June 2013. Methodology: Total 110 normal subjects and patients were recruited in the study after obtaining informed written consent. They were divided in to two groups. Group I was healthy controls (n=50) and Group II included subjects with MS (n=60) as per NCEP ATP III criteria. Anthropometric measurements & biochemical analysis was performed in all subjects. IR was defined by HOMA IR. Simple & multiple regression analysis were used to obtain relationship between IR (HOMA IR) using TG/HDL-C (model -1) and Apo-B (Model-2) as independent variables.Result: There were statistically significant differences in anthropometric, glycemic and lipid parameters between the control and study group (p0.0001).The regression model between HOMA IR and TG/HDL-C ratio showed a positive correlation, (r=0.29, p 0.05). HOMA IR & Apo-B also showed a significantly positive correlation (0. 41, p 0.001). But combined multivariate analysis indicated that Apo-B is a better predictor of IR compared to TG/HDL-C ratio.Conclusion: We concluded in our study that Apo-B may be a better predictor of IR than TG/HDL-C and hence could be adopted in routine laboratory practice as a lipid marker for prediction of insulin resistance (IR) in metabolic syndrome patients at an early stage.
机译:目的:本研究的目的是通过动态平衡评估胰岛素抵抗模型,评估载脂蛋白B(Apo-B)和甘油三酸酯/高密度脂蛋白胆固醇(TG / HDL-C)的比率作为胰岛素抵抗(IR)的指标。研究设计:观察性和前瞻性研究地点和持续时间:本研究于2012年3月至2013年6月在新孟买的米高梅医学院生物化学系和医学系进行。方法:获得知情同意书后,共招募了110名正常受试者和患者。他们分为两组。根据NCEP ATP III标准,第一组为健康对照组(n = 50),第二组包括MS组(n = 60)。在所有受试者中进行人体测量和生化分析。 IR由HOMA IR定义。使用TG / HDL-C(模型-1)和Apo-B(模型2)作为独立变量,通过简单多元回归分析获得IR(HOMA IR)之间的关系。结果:人体测量学,对照组和研究组之间的血糖和脂质参数(p <0.0001)。HOMAIR和TG / HDL-C比值之间的回归模型呈正相关(r = 0.29,p <0.05)。 HOMA IR和Apo-B也显示出显着的正相关(0. 41,p <0.001)。但是综合多变量分析表明,与TG / HDL-C比,Apo-B是更佳的IR预测指标。结论:我们在研究中得出的结论是,Apo-B可能比TG / HDL-C更好的IR预测指标,因此可以在常规实验室实践中用作脂质标记物,以早期预测代谢综合征患者的胰岛素抵抗(IR)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号